Teckro, the company transforming clinical trials for the world's leading pharmaceutical and emerging biotech firms, announced five significant appointments to its leadership team as it executes aggressive go-to-market and product strategies. The hires follow Teckro’s Series C funding announcement in February, featuring investment from major US venture capital firms. To date, Teckro has raised $43 million, with the latest round of $25 million earmarked for scale-up activities to accelerate growth and meet increased demand from leading pharmaceutical and emerging biotech companies looking to simplify and modernize clinical trials with Teckro.
The US Food and Drug Administration (FDA) on Monday finalized a rule for appealing decisions about medical devices regulated by the Center for Devices and Radiological Health (CDRH). The final rule is intended to fulfil requirements established under the Food and Drug Administration Safety and Innovation Act (FDASIA) and the 21st Century Cures Act to clarify procedures and timeframes for appealing “significant decisions” to CDRH supervisors and is set to take effect next month.
The Biotechnology Innovation Organization (BIO) today announced winners of the Start-up Stadium competition held last month at the BIO International Convention in Philadelphia. During five sessions over three days, live presentations of 50 finalists were evaluated by expert judges with entrepreneurial, investment, start-up, economic development, capital formation, and academic backgrounds from both the public and private sectors. One winner was chosen for each session. From 13 countries and 24 US states, competitors were judged on the strength of their commercially viable cutting-edge technologies and therapeutic solutions.